• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Illustration of multiple orange alarm clocks floating against a blue background scattered at different angles as if suspende
Special Reports

The top 10 drugs losing US exclusivity in 2026

While megablockbusters naturally command significant attention, Fierce takes a chance each year to look at older medicines nearing their tumble over the patent cliff.
Eric Sagonowsky , Fraiser Kansteiner , Kevin Dunleavy , Zoey Becker Mar 16, 2026 3:00am
The White House

Meds from Amgen, GSK now offered through TrumpRx DTC platform

Mar 16, 2026 11:33am
Biomarin

BioMarin halts dosing, enrollment in 3 midstage Voxzogo studies

Mar 16, 2026 11:26am
exit sign

Idorsia shares sink after CEO's abrupt departure

Mar 16, 2026 11:00am
Eli Lillys Lilly Seaport Innovation Center in Boston

Lilly's Ebglyss scores eczema trial win in children

Mar 16, 2026 10:50am
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

J&J alleges trade secret theft by former staffer linked to Summit

Mar 16, 2026 10:44am
More News

Bayer tees up Kerendia for major CKD label expansion

Mar 16, 2026 9:46am

Regulatory tracker: AZ's Imfinzi scores EU label expansion

Mar 16, 2026 9:20am

Bayer found to have discredited industry after Roche row

Mar 13, 2026 11:45am

Pfizer CEO Albert Bourla earns 2025 pay bump to $27.6M

Mar 13, 2026 11:26am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings